USECASE
Data-driven microbiome medicines for oncology
From microbiome sequencing to predictive models driving immunotherapy innovation.
USECASE
Researchers get insights in minutes instead of hours
An international pharmaceutical company sought to unlock the value of its data but lacked the expertise to build a fast, tailored platform, critical for reducing experiment processing from a full day to under an hour.